Inflammation and tuberculosis: host‐directed therapies

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2796|277|4|373-387

ISSN： 0954-6820

Source： JOURNAL OF INTERNAL MEDICINE, Vol.277, Iss.4, 2015-04, pp. : 373-387

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Opportunities and Challenges for Host-Directed Therapies in Tuberculosis

By  

Current Pharmaceutical Design, Vol. 22, Iss. 17, 2016-05 ,pp. : 2599-2604

Bentham Science Publishers

Access to resources Recommend Favorite

Host-directed therapy of tuberculosis: what is in it for microRNA?

By Iannaccone Marco   Dorhoi Anca   Kaufmann Stefan HE  

Expert Opinion on Therapeutic Targets, Vol. 18, Iss. 5, 2014-05 ,pp. : 491-494

Informa Healthcare

Access to resources Recommend Favorite

New tricks for old dogs: countering antibiotic resistance in tuberculosis with host‐directed therapeutics

By  

IMMUNOLOGICAL REVIEWS (ELECTRONIC), Vol. 264, Iss. 1, 2015-03 ,pp. : 344-362

John Wiley & Sons Inc

Access to resources Recommend Favorite

Systematic Approaches towards the Development of Host-Directed Antiviral Therapeutics

By Prussia Andrew   Thepchatri Pahk   Snyder James P.   Plemper Richard K.  

International Journal of Molecular Sciences, Vol. 12, Iss. 6, 2011-06 ,pp. : 4027-4052

MDPI

Access to resources Recommend Favorite

Identification of a Consensus Mutation in M Protein of Vesicular Stomatitis Virus from Persistently Infected Cells That Affects Inhibition of Host-Directed Gene Expression

By Ahmed M.   Lyles D.S.  

Virology, Vol. 237, Iss. 2, 1997-10 ,pp. : 378-388

Elsevier

Access to resources Recommend Favorite